| NDC Code | 68180-286-02 |
|---|
| Package Description | 1 BOTTLE in 1 CARTON (68180-286-02) > 500 TABLET in 1 BOTTLE |
|---|
| Product NDC | 68180-286 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Abacavir, Lamivudine And Zidovudine |
|---|
| Non-Proprietary Name | Abacavir , Lamivudine And Zidovudine |
|---|
| Dosage Form | TABLET |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20131217 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202912 |
|---|
| Manufacturer | Lupin Pharmaceuticals, Inc. |
|---|
| Substance Name | ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE |
|---|
| Strength | 300; 150; 300 |
|---|
| Strength Unit | mg/1; mg/1; mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Analog [EXT], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|